Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.52 |
| ▸ | TLR4 | O00206 | 5/20 | 0.51 |
| ▸ | LY96 | Q9Y6Y9 | 5/20 | 0.49 |
| ▸ | TK2 | O00142 | 2/20 | 0.48 |
| ▸ | PRKCA | P17252 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9404170 | 1.00 | LGALS8 (0.52) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL8895219 | 1.00 | LGALS8 (0.52) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL9846007 | 1.00 | LGALS8 (0.52) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL4267305 | 1.00 | LGALS8 (0.52) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL9404169 | 1.00 | LGALS8 (0.52) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL11797892 | 0.93 | TLR4 (0.56) | LGALS8TLR4LY96 | |
| SCHEMBL19409216 | 0.92 | LGALS8 (0.55) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL8194583 | 0.92 | LGALS8 (0.55) | LGALS8TLR4LY96TK2PRKCA | |
| SCHEMBL15953245 | 0.92 | LGALS8 (0.46) | LGALS8TLR4LY96TK2 | |
| SCHEMBL9114830 | 0.90 | TLR4 (0.54) | TLR4LY96TK2PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117757555-A | Environment-friendly wear-resistant lubricating oil and preparation method and application thereof | 正大国际科技(常德)集团有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117752619-A | Rifampicin powder injection and preparation method thereof | 卓和药业集团股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116285602-A | Aluminum alloy surface temperature-resistant corrosion-resistant coating and preparation method thereof | 南京信息工程大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116043223-A | Preparation method of weather-resistant carbon steel | 南京信息工程大学 | 2023-05-02 | — | — | CN | claimed |
| CN-115746789-A | Stable full-suspension diamond grinding fluid for grinding and preparation method thereof | 郑州磨料磨具磨削研究所有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115594976-A | Foam pore regulator, polyurethane foam and application and preparation method of foam pore regulator and polyurethane foam | 奥斯佳新材料技术研究（江苏）有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-113512196-B | Alcohol solution of alkyl silanol and preparation method | 中交上海三航科学研究院有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-110123659-B | Anti-hair loss composition and application thereof in preparation of anti-hair loss washing and protecting product | 名臣健康用品股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-109464295-B | Skin care composition containing low molecular weight fucooligosaccharide | 名臣健康用品股份有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-113512196-A | Alcohol solution of alkyl silanol and preparation method | 中交上海三航科学研究院有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-1872692-A | Preparation method of hydration-resistant easily-dispersible aluminum nitride powder | UNIV NANJING POLYTECHNIC (CN) | 2006-12-06 | — | — | CN | claimed |
| CN-1775214-A | Rifapentine, refampicin, rifabutin or rifamdin injection and its preparing method | UNIV WUHAN (CN) | 2006-05-24 | — | — | CN | claimed |
| CN-1256079-C | Whitening and water compensating skin caring cosmetic without essence, coloring matter, mineral oil or antiseptic | GUANGZHOU CAISY COSMETIC CO LT (CN) | 2006-05-17 | — | — | CN | claimed |
| US-20050188478-A1 | Composition for dyeing keratin fibers, comprising at least one alcohol oxidase and at least one sugar-based nonionic surfactant, and a process using this composition | L'OREAL S.A. (FR) | 2005-09-01 | — | — | US | claimed |
| CN-1628632-A | Whitening and water compensating skin caring cosmetic without essence, coloring matter, mineral oil or antiseptic | GUANGZHOU CAISY COSMETIC CO LT (CN) | 2005-06-22 | — | — | CN | claimed |
| CN-1176655-C | Refapentine or rifampin liposome perfusate, injection and preparation process thereof | 广一平 | 2004-11-24 | — | — | CN | claimed |
| EP-1047389-B1 | DYEING COMPOSITION FOR KERATINOUS FIBRES WITH DIRECT CATIONIC COLOURING AGENT AND A NON-IONIC SURFACTANT | OREAL (FR) | 2004-07-07 | — | — | EP | claimed |
| CN-1390894-A | Electrically conductive paint for internal surface of battery shell and its preparing process | FUQI CHEMICAL CO LTD HUIZHOU (CN) | 2003-01-15 | — | — | CN | claimed |
| CN-1319395-A | Refapentine or rifampin liposome perfusate, injection and preparation process thereof | WUHAN TUBERCULOSIS PREVETION A (CN) | 2001-10-31 | — | — | CN | claimed |
| CN-1309966-A | Rifapentine or Rifampicin microemulsion and suspension perfusate and injection and their preparation | UNIV WUHAN (CN) | 2001-08-29 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050188478-A1 | Composition for dyeing keratin fibers, comprising at least one alcohol oxidase and at least one sugar-based nonionic surfactant, and a process using this composition | KRT18, SORD, HKDC1 | LGALS8 487/4885TLR4 3753/4885LY96 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.